What’s in this podcast?
Join host Jason Foster in a fascinating conversation with Volodimir Olexiouk, Director of Scientific Engagement at BioLizard. Together, they delve into the revolutionary intersection of artificial intelligence and pharmaceuticals, exploring how AI is transforming the landscape of drug discovery.
Tune in now and gain insights into the innovative ways AI is transforming drug discovery and shaping the future of healthcare and biotechnology.
Listen to this episode on Spotify, iTunes, and Stitcher. You can also catch up on the previous episodes of the Hub & Spoken podcast when you subscribe.
What are your thoughts on this topic? We’d love to hear from you; join the discussion and let us know on LinkedIn.
___
Check out our free AI Scorecard and we’ll send you a personalised report that outlines what’s needed to drive innovation to your business and be competitive.
